Clinical Trials for B Acute Lymphoblastic Leukemia

Find clinical trials for b acute lymphoblastic leukemia. Discover research opportunities and treatment options in your area.

16 Active Trials Found

Showing 16 trials on this page

Page 1 of 1

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

NCT ID: NCT06317662

This clinical trial is studying whether adding two specific anti-cancer treatments, called venetoclax and blinatumomab, to the usual chemotherapy can help infants with a type of leukemia known as a...

Recruiting

Phase: PHASE2 Type: interventional Locations: Little Rock, Arkansas, United States, Jackson, Mississippi, United States +21 more

Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation

NCT ID: NCT03856216

This clinical trial is studying a new treatment approach for patients with certain types of leukemia and lymphoma who are preparing for a stem cell transplant. The researchers want to find out if a...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

A Study Comparing the Combination of Dasatinib or Imatinib and Chemotherapy Treatment With or Without Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-Cell Acute Lymphoblastic Leukemia (B-ALL)

NCT ID: NCT06124157

This clinical trial is studying a new treatment approach for children, adolescents, and young adults with a type of leukemia called Philadelphia chromosome positive (Ph+) or Philadelphia chromosome...

Recruiting

Phase: PHASE3 Type: interventional Locations: Philadelphia, Pennsylvania, United States, Norfolk, Virginia, United States +14 more

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

NCT ID: NCT03959085

This clinical trial is studying a treatment for patients with certain types of high-risk blood cancers, specifically High-Risk B-cell Acute Lymphoblastic Leukemia (B-ALL), Mixed Phenotype Acute Leu...

Recruiting

Phase: PHASE3 Type: interventional Locations: New Haven, Connecticut, United States, Lebanon, New Hampshire, United States +241 more

JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia

NCT ID: NCT06940960

This clinical trial is testing a new treatment called JY231 injection for patients with certain types of blood cancers, specifically relapsed or refractory B cell lymphoma and leukemia. This means ...

Recruiting

Phase: NA Type: interventional Locations: Guangzhou, Guangdong, China

Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia

NCT ID: NCT02877303

This clinical trial is studying a combination of three treatments—blinatumomab, inotuzumab ozogamicin, and standard chemotherapy—to see how effective they are as the first line of treatment for pat...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia

NCT ID: NCT06890065

This clinical trial is looking at a new treatment called JY231 injection for patients with relapsed or refractory B cell lymphoma and leukemia, specifically B Acute Lymphoblastic Leukemia (B-ALL) a...

Recruiting

Phase: NA Type: interventional Locations: Zhengzhou, Henan, China

Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia

NCT ID: NCT05157971

This clinical trial is looking at how safe and effective a new treatment is for adults with a type of blood cancer called B-cell acute lymphoblastic leukemia (ALL). The treatment combines a drug ca...

Recruiting

Phase: PHASE1 Type: interventional Locations: Duarte, California, United States

Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia

NCT ID: NCT06710418

This clinical trial is studying how different levels of hemoglobin, a protein in red blood cells that carries oxygen, affect the quality of life and daily functioning of patients with certain blood...

Not yet recruiting

Phase: NA Type: interventional Locations: Seattle, Washington, United States

Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma

NCT ID: NCT05602194

This clinical trial is investigating whether adding a medication called levocarnitine to standard chemotherapy can help protect the liver in patients with certain types of leukemia or lymphoma. The...

Recruiting

Phase: PHASE3 Type: interventional Locations: Chicago, Illinois, United States, Cleveland, Ohio, United States +222 more

Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia

NCT ID: NCT04872790

This clinical trial is studying a combination of four medications—venetoclax, dasatinib, prednisone, rituximab, and blinatumomab—to see how well they work in treating patients with a specific type ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Portland, Oregon, United States

Inotuzumab Ozogamicin in Treating Patients With B-cell Acute Lymphocytic Leukemia With Positive Minimal Residual Disease

NCT ID: NCT03441061

This clinical trial is studying a treatment called inotuzumab ozogamicin for patients with a type of blood cancer known as B-cell acute lymphoblastic leukemia (ALL). Specifically, it focuses on pat...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

NCT ID: NCT05281809

This clinical trial is exploring a new method to produce and deliver CAR T-cell therapy for patients with certain types of B-cell cancers, including B-Cell Lymphoma and B-Acute Lymphoblastic Leukem...

Recruiting

Phase: PHASE2 Type: interventional Locations: Pittsburgh, Pennsylvania, United States

Combination of an Anti-PD1 Antibody With Tisagenlecleucel Reinfusion in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia After Loss of Persistence

NCT ID: NCT05310591

This clinical trial is studying a new treatment approach for children, adolescents, and young adults aged 1 to 25 years who have a type of blood cancer called Acute Lymphoblastic Leukemia (B-ALL) t...

Recruiting

Phase: PHASE1 Type: interventional Locations: Nancy, , France, Lille, , France +10 more

CD19CD22 CAR-T Therapy in Patients With High-Risk B Acute Lymphoblastic Leukemia (B-ALL).

NCT ID: NCT06078306

This clinical trial is testing a new treatment called CD19CD22 CAR-T therapy for adults who have recently been diagnosed with high-risk B Acute Lymphoblastic Leukemia (B-ALL). The goal of the study...

Recruiting

Phase: PHASE2 Type: interventional Locations: Suzhou, Jiangsu, China

Monitoring Minimal Residual Disease（MRD）in Pediatric B-acute Lymphoblastic Leukemia

NCT ID: NCT04977895

This clinical trial is studying a new method to detect minimal residual disease (MRD) in children with B-acute lymphoblastic leukemia (B-ALL), a type of blood cancer. The researchers want to see ho...

Recruiting

Type: observational Locations: Guangzhou, Guangdong, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions